Our Mission
ACRO advocates as the collective voice of innovative clinical research and technology organizations to regulators and policymakers, educating stakeholders and advocating for policies that foster efficient, effective and safe conduct of clinical research.
About ACRO
Founded in 2002, ACRO represents the world’s leading clinical research and technology organizations, which provide specialized services that are integral to the development of drugs, biologics and medical devices.
ACRO and its members advocate on a global basis for safe, ethical, high-quality medical research so patients can benefit from the development of new treatments and therapies. Our members are dedicated to helping their clients bring efficiency, innovation and value to the clinical research process. ACRO member companies employ over 410,000 people worldwide, conduct research in nearly every global region, and generate an estimated $98 billion in revenue per year.
Each year, our members support the administration of thousands of clinical studies. In 2024, our members conducted or participated in 8,854 studies involving nearly two million research participants across a wide range of therapeutic areas and geographies.
The Association of Clinical Research Organizations is organized as a non-profit trade association under Section 501(c)(6) of the Internal Revenue Code of the United States.
Advancing Clinical Research, Together
ACRO members:
- Advance clinical outsourcing to improve the quality, efficiency and safety of biomedical research
- Conduct thousands of clinical trials around the world while ensuring the safety of research participants
- Strengthen public understanding and confidence in clinical research, highlighting member company expertise in all aspects of the clinical research enterprise
ACRO is a leading voice for safe and ethical clinical trials, working with stakeholders globally to promote a better and more efficient clinical trial process. We are dedicated to bringing efficiency, innovation and value to the clinical research process and to highlighting the important contribution that clinical research and technology companies make as partners in the development of new medicines and new treatments that benefit millions of patients worldwide.
ACRO is a hub for peer-to-peer networking and our working groups facilitate thought leadership, industry-wide discussion and action on key issues. We build relationships with regulators from the FDA, EMA and other agencies, providing input and subject matter expertise on a variety of regulatory issues. ACRO links members with industry stakeholder groups like EFPIA, PhRMA, BIO, and TransCelerate.